A little about us
Who we are
At Atlas Biotech, we are driven by the idea that curative treatments for many devastating diseases are within reach, we just need the right tools and data to get us there.
The founding team spun Atlas Biotech’s mutational scanning technology out of Penn State in 2024, and we’ve been adding team members who share our excitement for science and solving challenging problems.
Where we’re going
Our work has historically been centered in oncology, but we are developing applications for our technologies in rare diseases, inflammatory disease models, and more.
With the demand for data at an all-time high, we aim to be a key provider of high quality datasets including massively multiplexed genotype-phenotype measurements, genome-wide screens, and other sources of big data.
What we do
We specialize in functional genomics and other synthetic biology techniques, which provide deeper insights into structure-function relationships that drive biology and disease.
Designing and screening libraries is our bread and butter, but we’re also interested in developing novel assays that answer niche or specifically challenging questions.